DESCOVY (emtricitabine and tenofovir alafenamide) is a fixed dose combination tablet containing emtricitabine (FTC) and tenofovir alafenamide (TAF) for oral administration. … TAF, an HIV NRTI, is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate.
Descovy contains a combination of emtricitabine and tenofovir alafenamide. Emtricitabine and tenofovir alafenamide are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. Descovy is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS).
- changes in body fat distribution.
- changes in your immune system.
- new or worse kidney problems, including kidney failure,
- bone problems such as bone pain, softening, or thinning and fractures, or.
- increased cholesterol.